Cargando…

Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2

BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, G-H., Park, S-H., Song, B-M., Kim, D-M., Han, H-J., Park, J-Y., Jo, Y-W., Hwang, M-Y., Sim, K-T., Kang, S-M., Tark, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639569/
https://www.ncbi.nlm.nih.gov/pubmed/36183929
http://dx.doi.org/10.1016/j.jhin.2022.09.011
_version_ 1784825668947673088
author Lee, G-H.
Park, S-H.
Song, B-M.
Kim, D-M.
Han, H-J.
Park, J-Y.
Jo, Y-W.
Hwang, M-Y.
Sim, K-T.
Kang, S-M.
Tark, D.
author_facet Lee, G-H.
Park, S-H.
Song, B-M.
Kim, D-M.
Han, H-J.
Park, J-Y.
Jo, Y-W.
Hwang, M-Y.
Sim, K-T.
Kang, S-M.
Tark, D.
author_sort Lee, G-H.
collection PubMed
description BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants. AIM: To evaluate the virucidal efficacy of 72 commercially available disinfectants constituting 16 types of ingredients against SARS-CoV-2. METHODS: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3–5 days of SARS-CoV-2 infection. FINDINGS: This study found that disinfectants based on 83% ethanol, 60% propanol/ethanol, 0.00108–0.0011% sodium dichloroisocyanurate and 0.497% potassium peroxymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05–0.4% benzalkonium chloride (BAC), 0.02–0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205–0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04–4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205–0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2. CONCLUSION: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concentration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid.
format Online
Article
Text
id pubmed-9639569
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
record_format MEDLINE/PubMed
spelling pubmed-96395692022-11-14 Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 Lee, G-H. Park, S-H. Song, B-M. Kim, D-M. Han, H-J. Park, J-Y. Jo, Y-W. Hwang, M-Y. Sim, K-T. Kang, S-M. Tark, D. J Hosp Infect Article BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants. AIM: To evaluate the virucidal efficacy of 72 commercially available disinfectants constituting 16 types of ingredients against SARS-CoV-2. METHODS: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3–5 days of SARS-CoV-2 infection. FINDINGS: This study found that disinfectants based on 83% ethanol, 60% propanol/ethanol, 0.00108–0.0011% sodium dichloroisocyanurate and 0.497% potassium peroxymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05–0.4% benzalkonium chloride (BAC), 0.02–0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205–0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04–4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205–0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2. CONCLUSION: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concentration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid. The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2023-01 2022-09-30 /pmc/articles/PMC9639569/ /pubmed/36183929 http://dx.doi.org/10.1016/j.jhin.2022.09.011 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lee, G-H.
Park, S-H.
Song, B-M.
Kim, D-M.
Han, H-J.
Park, J-Y.
Jo, Y-W.
Hwang, M-Y.
Sim, K-T.
Kang, S-M.
Tark, D.
Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
title Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
title_full Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
title_fullStr Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
title_full_unstemmed Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
title_short Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
title_sort comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639569/
https://www.ncbi.nlm.nih.gov/pubmed/36183929
http://dx.doi.org/10.1016/j.jhin.2022.09.011
work_keys_str_mv AT leegh comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT parksh comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT songbm comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT kimdm comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT hanhj comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT parkjy comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT joyw comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT hwangmy comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT simkt comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT kangsm comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2
AT tarkd comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2